Risk communication in consultations about hormone therapy in the menopause: concordance in risk assessment and framing due to the context

References

• Whitney S N, McGuire A L, McCullough L B. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004; 140: 54–59
   PubMed Web of Science ®Google Scholar
• Edwards A, Elwyn G. Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care 2001; 10(Suppl 1)I9–I13
   PubMedGoogle Scholar
• Bogardus S T, Jr., Holmboe E, Jekel J F. Perils, pitfalls, and possibilities in talking about medical risk. JAMA 1999; 281: 1037–1041
   PubMed Web of Science ®Google Scholar
• Kjellgren K I, Ahlner J, Dahlöf B, Gill H, Hedner T, Säljö R. Patients' and physicians' assessment of risks associated with hypertension and benefits from treatment. J Cardiovasc Risk 1998; 5: 161–166
   PubMedGoogle Scholar
• Braddock C H, III, Edwards K A, Hasenberg N M, Laidley T L, Levinson W. Informed decision making in outpatient practice: Time to get back to basics. JAMA 1999; 282: 2313–2320
   PubMed Web of Science ®Google Scholar
• Fagerberg C R, Kragstrup J, Stovring H, Rasmussen N K. How well do patient and general practitioner agree about the content of consultations?. Scand J Prim Health Care 1999; 17: 149–152
   PubMed Web of Science ®Google Scholar
• Marvel M K, Epstein R M, Flowers K, Beckman H B. Soliciting the patient's agenda: have we improved?. JAMA 1999; 281: 283–287
   PubMed Web of Science ®Google Scholar
• Elwyn G, Edwards A, Wensing M, Hibbs R, Wilkinson C, Grol R. Shared decision making observed in clinical practice: visual displays of communication sequence and patterns. J Eval Clin Pract 2001; 7: 211–221
   PubMed Web of Science ®Google Scholar
• Griffiths F, Green E, Tsouroufli M. The nature of medical evidence and its inherent uncertainty for the clinical consultation: Qualitative study. Br Med J 2005; 330: 511
   PubMed Web of Science ®Google Scholar
• Elwyn G, Edwards A, Mowle S, et al. Measuring the involvement of patients in shared decision-making: a systematic review of instruments. Patient Educ Couns 2001; 43: 5–22
   PubMed Web of Science ®Google Scholar
• Beck R S, Daughtridge R, Sloane P D. Physician–patient communication in the primary care office: a systematic review. J Am Board Fam Pract 2002; 15: 25–38
   PubMedGoogle Scholar
• Wu W C, Pearlman R A. Consent in medical decision making. J Gen Intern Med 1988; 3: 9–14
   PubMed Web of Science ®Google Scholar
• Kalet A, Roberts J C, Fletcher R. How do physicians talk with their patients about risks?. J Gen Intern Med 1994; 9: 402–404
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Lindh-Åstrand L, Ahlner J, Hammar M, Kjellgren K I. Hormone replacement therapy in the menopause. Structure and content of risk talk. Maturitas 2005; 50: 8–18
   PubMed Web of Science ®Google Scholar
• Bjerrum L, Hamm L, Toft B, Munck A, Kragstrup J. Do general practitioner and patient agree about the risk factors for ischaemic heart disease?. Scand J Prim Health Care 2002; 20: 16–21
   PubMed Web of Science ®Google Scholar
• Paling J. Strategies to help patients understand risks. Br Med J 2003; 327: 745–748
   PubMed Web of Science ®Google Scholar
• Becker M H, Maiman L A. Strategies for enhancing patient compliance. J Community Health 1980; 6: 113–135
   PubMedGoogle Scholar
• Alaszewski A, Horlick-Jones T. How can doctors communicate information about risk more effectively?. Br Med J 2003; 327: 728–731
   PubMed Web of Science ®Google Scholar
• Epstein R M, Alper B S, Quill T E. Communicating evidence for participatory decision making. JAMA 2004; 291: 2359–2366
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Linell P, Lindh-Åstrand L, Kjellgren K I. Risk talk: rhetorical strategies in consultations on hormone replacement therapy. Health, Risk & Society 2003; 5: 139–154
   Web of Science ®Google Scholar
• Edwards R, Wiholm B -E, Martinez C. Concepts in risk-benefit assessment: a simple merit analysis of a medicine?. Drug Safety 1996; 1: 1–7
   Google Scholar
• Risk: Analysis, perception and management. Royal Society, London 1992
   Google Scholar
• Neil N, Malmfors T, Slovic P. Intuitive toxicology: expert and lay judgments of chemical risks. Toxicol Pathol 1994; 22: 198–201
   PubMed Web of Science ®Google Scholar
• Slovic P. Intuitive toxicology. II. Expert and lay judgments of chemical risks in Canada. Risk Analysis 1995; 15: 661–675
   Web of Science ®Google Scholar
• Asch D A, Hershey J C. Why some health policies don't make sense at the bedside. Ann Intern Med 1995; 122: 846–850
   PubMed Web of Science ®Google Scholar
• Redelmeier D A, Tversky A. Discrepancy between medical decisions for individual patients and for groups. N Engl J Med 1990; 322: 1162–1164
   PubMed Web of Science ®Google Scholar
• Risk assessment in the federal government: Managing the process. National Research Council, Washington, DC 1983
   Google Scholar
• Starr C. Social benefit versus technological risk. Science 1969; 165: 1232–1238
   PubMed Web of Science ®Google Scholar
• Slovic P. Perception of risk. Science 1987; 236: 280–285
   PubMed Web of Science ®Google Scholar
• Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science 1981; 211: 453–458
   PubMed Web of Science ®Google Scholar
• Tversky A, Kahneman D. Judgement under uncertainty: heuristics and biases. Science 1974; 185: 1124–1131
   PubMed Web of Science ®Google Scholar
• Ballard K. Understanding risk: women's perceived risk of menopause-related disease and the value they place on preventive hormone replacement therapy. Fam Pract 2002; 19: 591–595
   PubMed Web of Science ®Google Scholar
• Scheid D C, Coleman M T, Hamm R M. Do perceptions of risk and quality of life affect use of hormone replacement therapy by postmenopausal women?. J Am Board Fam Pract 2003; 16: 270–277
   PubMedGoogle Scholar
• Edwards A, Hood K, Matthews E, et al. The effectiveness of one-to-one risk communication interventions in health care: a systematic review. Med Decis Making 2000; 20: 290–297
   PubMed Web of Science ®Google Scholar
• Walter F M, Britten N. Patients' understanding of risk: a qualitative study of decision-making about the menopause and hormone replacement therapy in general practice. Fam Pract 2002; 19: 579–586
   PubMed Web of Science ®Google Scholar
• Walter F M, Emery J D, Rogers M, Britten N. Women's views of optimal risk communication and decision making in general practice consultations about the menopause and hormone replacement therapy. Patient Educ Couns 2004; 53: 121–128
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49–57
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G L, Prentice R L, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–427
   PubMed Web of Science ®Google Scholar
• Nilsson J L, Johansson H, Wennberg M. Large differences between prescribed and dispensed medicines could indicate undertreatment. Drug Inform J 1995; 29: 1243–1246
   Google Scholar
• O'Connor A, Stacey D, Rovner D, et al. Decision aids for people facing health treatment or screening decisions. The Cochrane Database of Systematic Reviews 2003, Issue 1, Art. No. CD001431. DOI: 10.1002/14651858. CD001431
   Google Scholar